InspireMD (NSPR) Capital Expenditures Growth (3y) (2013 - 2025)
InspireMD (NSPR) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.52% |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn | 61.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.21% |
| Sep 30, 2025 | 13.33% |
| Jun 30, 2025 | 71.10% |
| Mar 31, 2025 | 113.29% |
| Dec 31, 2024 | 42.71% |
| Sep 30, 2024 | 38.93% |
| Jun 30, 2024 | 106.43% |
| Mar 31, 2024 | 95.74% |
| Dec 31, 2023 | 51.36% |
| Dec 31, 2022 | 21.47% |
| Sep 30, 2022 | 50.73% |
| Jun 30, 2022 | 5.12% |
| Mar 31, 2022 | -17.54% |
| Dec 31, 2021 | 42.47% |
| Sep 30, 2021 | 328.18% |
| Jun 30, 2021 | 25.99% |
| Mar 31, 2021 | 196.25% |
| Dec 31, 2020 | 43.46% |
| Dec 31, 2019 | 13.76% |
| Sep 30, 2019 | 220.75% |